Elekta AB (publ) (OTCMKTS:EKTAY) Posts Quarterly Earnings Results, Misses Expectations By $0.01 EPS

Elekta AB (publ) (OTCMKTS:EKTAY) issued its quarterly earnings data on Friday. The company reported $0.08 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.01), Zacks reports. Elekta AB (publ) had a net margin of 5.65% and a return on equity of 11.07%.

Elekta AB (publ) Trading Up 0.4 %

OTCMKTS EKTAY traded up $0.03 during mid-day trading on Friday, reaching $6.09. 1,474 shares of the stock were exchanged, compared to its average volume of 4,729. Elekta AB has a one year low of $5.25 and a one year high of $8.24. The stock has a 50 day simple moving average of $5.72 and a 200-day simple moving average of $6.09. The stock has a market cap of $2.34 billion, a P/E ratio of 24.36 and a beta of 1.22. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.05 and a quick ratio of 0.81.

Elekta AB (publ) Cuts Dividend

The company also recently announced a dividend, which will be paid on Thursday, March 27th. Investors of record on Friday, March 7th will be paid a dividend of $0.1072 per share. The ex-dividend date of this dividend is Friday, March 7th. Elekta AB (publ)’s dividend payout ratio is presently 48.00%.

Wall Street Analysts Forecast Growth

Separately, Sanford C. Bernstein raised shares of Elekta AB (publ) from a “strong sell” rating to a “hold” rating in a research note on Wednesday, January 29th.

About Elekta AB (publ)

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.